-
Complement System
- Classical Pathway
- Complement Therapeutic Target-C1 Complex
- Complement Therapeutic Target-C1 Inhibitor
- Complement Therapeutic Target-C2
- Complement Therapeutic Target-C3
- Complement Therapeutic Target-C4
- Complement Therapeutic Target-C5
- Complement Therapeutic Target-C5aR
- Complement Therapeutic Target-C3 Convertases
- Complement Therapeutic Target-C5 Convertases
- Lectin Pathway
- Alternative Pathway
- Membrane Attack Complex
- Classical Pathway
- Indication
-
Services
- Therapeutic Antibody Development
- Complement Tests
- Complement Function/Activity Tests
- • Total Complement Activity Test
-
• Individual Component Activity Tests
- C1q-Binding Assay
- C2 Functional Test
- C3 Functional Test
- C5 Functional Test
- Factor B Functional Test
- Factor D Functional Test
- Factor H Functional Test
- Factor I Functional Assay
- Factor P Functional Test
- C1 Inhibitor Functional Test
- C1 Complex Functional Test
- C5b-9 Complex Functional Test
- C5a Functional Test
- C5b Functional Test
- C5 Convertase Functional Test
- C3a Functional Test
- C3b Functional Test
- C3 Convertase Functional Test
- C1r Functional Test
- C1s Functional Test
- • Complement Activation Product Tests
- • Haemolysis Inhibition Assay
- • Complement Inhibitor Validation
- • Receptor Ligand Binding Assay
- • Cell-based Complement Activity Assays
- • Anticomplementary Activity Assay
- Complement Autoantibody Tests
- Complement Genetic Test
- Complement Multiplex Assay
- Complement Function/Activity Tests
- Complement Component Inhibitor Development
- Products
- Support
- Company
